Search - tctmd.com

Displaying 461 - 480 of 719

Sort: Relevancy | Date

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Conference News HRS 2018

Military Veterans With PTSD Are at Risk for A-fib

Todd Neale

May 10, 2018

News Conference News HRS 2018

Increasing Air Pollution May Spark Sudden Cardiac Death in Women

Todd Neale

May 09, 2018

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Caitlin E. Cox

May 09, 2018

News Daily News

Indoor Smoking Bans' Ability to Cut CVD Suggests Need to Expand Policies

L.A. McKeown

May 09, 2018

Podcast

Quantitative Flow Ratio, Live Cases, and More

May 09, 2018

News Industry News

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

May 08, 2018

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

Michael O'Riordan

May 07, 2018

News Daily News

Some Sex Differences Disappear With an Improved STEMI Protocol

Todd Neale

May 07, 2018

News Industry News

Abott Implements Corrective Action for Heartmate 3 Heart Pump

May 07, 2018

Presentation EAS 2018

Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial

Presenter: Michelle L. O’Donoghue

May 07, 2018

Presentation EAS 2018

LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis

Presenter: Brian A. Ference

May 07, 2018

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

Presentation EAS 2018

Stress, Behavior and Cardiovascular Disease

Presenter: Viola Vaccarino

May 06, 2018

News Conference News SCAI 2018

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

L.A. McKeown

May 04, 2018

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

Advertisement

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Military Veterans With PTSD Are at Risk for A-fib

Increasing Air Pollution May Spark Sudden Cardiac Death in Women

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Indoor Smoking Bans' Ability to Cut CVD Suggests Need to Expand Policies

Quantitative Flow Ratio, Live Cases, and More

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

Some Sex Differences Disappear With an Improved STEMI Protocol

Abott Implements Corrective Action for Heartmate 3 Heart Pump

Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial

LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Stress, Behavior and Cardiovascular Disease

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

Alirocumab Price Slashed in Deal With Express Scripts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content